For Industry

Patient-Focused Drug Development Consultation Meetings

FDA is convening a series of consultation meetings with patient stakeholders to address key considerations and challenges in establishing a process for conducting a series of patient-focused drug development meetings that will be useful to both the patient community and FDA.

 

Page Last Updated: 09/04/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.